No black box warning on record for Hadlima

As of the latest FDA labeling reviewed, Hadlima (ADALIMUMAB-BWWD) does not carry a black box warning. Standard warnings and precautions still apply — see the full Hadlima medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious infections: Do not start HADLIMA during an active infection. If an infection develops, monitor carefully, and stop HADLIMA if infection becomes serious ( 5.1 ) • Invasive fungal infections: For patients who develop a systemic illness on HADLIMA, consider empiric antifungal therapy for those who reside or travel to regions where mycoses are endemic ( 5.1 ) • Mal

No black box warning on record for Hadlima

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serious infections: Do not start HADLIMA during an active infection. If an infection develops, monitor carefully, and stop HADLIMA if infection becomes serious ( 5.1 ) • Invasive fungal infections: For patients who develop a systemic illness on HADLIMA, consider empiric antifungal therapy for those who reside or travel to regions where mycoses are endemic ( 5.1 ) • Mal

Hadlima Black Box Warning

No black box warning on record for Hadlima

Other warnings & precautions

Hadlima Black Box Warning

No black box warning on record for Hadlima

Other warnings & precautions